Ping An's earnings and dividend growth visibility strengthens; JPMorgan modestly raises A/H-share target prices and maintains top-pick Overweight

Overview

The report updates its earnings model following Ping An's solid 1H26 operating data and more positive growth signals. JPMorgan believes that a recovery in life insurance sales, stabilizing quality of the in-force life insurance reserve book, improved profitability in non-life businesses, renewed CSM accumulation, and ample parent-company cash will enhance visibility into core earnings and dividends over the next three years. Despite improving fundamentals, A/H-share valuations remain low, so the report maintains its top-pick Overweight view and modestly raises its target prices.

Core views

First, JPMorgan believes Ping An's 1H26 results showed favorable operating indicators, while management expressed greater confidence in business growth at the results briefing. This strengthens market confidence in a sustained life insurance recovery and shareholder returns more than the single-period profit itself. New business value (NBV) growth across diversified channels remained resilient, and the report also expects the agent headcount to post net growth in 2026 and beyond. Recovering life insurance sales, stable quality of the in-force life insurance reserve book, and an improving earnings mix in non-life businesses together form the foundation for core earnings growth over the next three years. Based on these changes, the report modestly raises Ping An's OPAT forecasts to Rmb151.0bn for FY26E, Rmb171.0bn for FY27E, and Rmb194.0bn for FY28E, corresponding to year-over-year growth of 12%, 13%, and 13%. As the company's dividend policy is broadly linked to OPAT growth, JPMorgan expects double-digit core earnings growth to flow through to DPS. DPS forecasts for FY26E, FY27E, and FY28E are Rmb3.00, Rmb3.39, and Rmb3.85, respectively. The main text uses year-over-year growth rates of 11%, 13%, and 13%, while the precise growth rates in the financial tables are 11.3%, 12.9%, and 13.5%. This earnings-dividend linkage is central to the report's positive view on the visibility of shareholder returns. Second, the life insurance contractual service margin (CSM) has reached a clearer inflection point. Ping An's CSM balance returned to positive growth as of June 2026, supported by strong growth in new business CSM and positive CSM variances. JPMorgan believes diversified distribution channels and productivity improvements will enable continued CSM accumulation and expects the balance to grow by 2.9%, 4.6%, and 5.6% at year-end 2026, 2027, and 2028, reaching approximately Rmb746.0bn, Rmb781.0bn, and Rmb825.0bn, respectively. The corresponding figures in the financial tables are Rmb746.419bn, Rmb781.045bn, and Rmb824.799bn. New business CSM is forecast at Rmb61.160bn, Rmb77.044bn, and Rmb89.162bn, respectively. The report expects new business CSM to exceed CSM release in 2027, resulting in stronger CSM balance growth and further scope for dividend increases. Third, the report judges that declining solvency will not constrain business expansion or shareholder returns during the current forecast period. The group's core solvency adequacy ratio is expected to decline from 166% in June 2026 to 164% at year-end 2026, 152% at year-end 2027, and 139% at year-end 2028, but is still considered sufficient to support operations. Parent-company free cash reached Rmb81.7bn as of June 2026, up 20% year-to-date, and upstream dividends are sufficient to cover shareholder distributions. JPMorgan expects the parent company's cash balance to remain broadly stable, supporting business growth and steady dividend growth across market cycles. Fourth, low interest rates remain a key source of pressure on the balance sheet. Declining Chinese bond yields could weaken the balance sheet and reduce solvency and dividend capacity. The market has already significantly discounted this concern, with the H-share P/B declining from 2.2x in FY19 to 0.8x in FY26E and the A-share P/B declining to 0.9x. The report believes that the company's strengthened solvency risk management, adoption of more reasonable actuarial assumptions, and reduced exposure to higher-risk investments such as non-standard assets will help mitigate these pressures. Combined with renewed growth in the life insurance business, JPMorgan judges the risk of a material decline in earnings and dividends over the coming years to be relatively limited. Finally, valuation remains an important basis for the report's positive view. Ping An's H-shares and A-shares trade at approximately 5x and 6x FY27E P/E, with expected dividend yields of 7.0% and 6.2%, respectively. The report states that both offer the most attractive risk-reward among Chinese listed insurers, with the dividend yields of both H-shares and A-shares ranking among the highest in the industry. JPMorgan modestly raises its December 2027 H-share target price from HK$95 to HK$98 and its A-share target price from Rmb88 to Rmb91. The target prices are based on a sum-of-the-parts valuation: the life insurance, non-life insurance, and securities businesses are assigned FY27E P/E multiples of 10x, 7x, and 5x, respectively; the banking business is assigned 0.4x FY27E book value; and the market value of listed fintech and healthtech subsidiaries is included.

Analysis framework

The report first uses 1H26 operating data and management guidance to assess whether life insurance growth is sustainable, then maps the quality of life insurance reserves, non-life business profitability, and multichannel new business growth into OPAT forecasts for the next three years. It then derives DPS through the linkage between OPAT and dividend policy, tests the future visibility of life insurance profits using new business CSM, CSM release, and balance roll-forward, and assesses the sustainability of shareholder returns using core solvency, parent-company free cash, and upstream dividend coverage. Finally, the report uses a sum-of-the-parts approach to value the life insurance, non-life insurance, securities, banking, and listed technology subsidiaries separately, and combines P/E, dividend yield, and the historical P/B discount to determine target prices and ratings.

Methodology notes

• Valuation MethodSOTP Valuation

  Sum-of-the-parts valuation

  The report estimates the values of the life insurance, non-life insurance, securities, and banking businesses separately, then adds the market value of the listed fintech and healthtech subsidiaries to derive the A-share and H-share target prices.

• Valuation MethodPE/PEG valuation

  Business-segment P/E valuation

  The life insurance, non-life insurance, and securities businesses are valued at 10x, 7x, and 5x FY27E P/E, respectively, reflecting the different earnings characteristics and valuation levels of each business.

• Valuation MethodPB valuation

  P/B valuation of the banking business

  The banking business is valued at 0.4x FY27E book value. The report also compares FY19 and FY26E P/B multiples to illustrate the market discount for low interest rates and balance-sheet risks.

• Financial Industry-Specific MetricsSolvency analysis

  Core solvency and capacity to support shareholder returns

  The report forecasts the group's core solvency adequacy ratio and combines it with parent-company free cash and upstream dividend coverage to determine whether capital will constrain business growth or dividends.

• Financial Industry-Specific Metrics

  Contractual service margin (CSM) roll-forward analysis

  The report uses new business CSM, CSM release, changes in variances, and the ending CSM balance to assess the accumulation and release profile of future life insurance profits, and views new business CSM exceeding CSM release in 2027 as the key inflection point for accelerating balance growth.

• Corporate Fundamentals and Financial FrameworkFree cash flow analysis

  Parent-company free cash and upstream dividend coverage analysis

  The report uses the parent company's free cash balance and the extent to which upstream dividends cover shareholder distributions to assess the group's financial capacity to fund both business investment and dividends.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Ping An H-shares (2318.HK)

  The report maintains its Overweight rating and top-pick status in the China insurance sector and raises its December 2027 target price to HK$98.

  Strengths

  Approximately 5x FY27E P/E and a 7.0% dividend yield; a life insurance recovery, CSM accumulation, OPAT growth, and parent-company cash support dividend upside.

  Weaknesses

  Declining Chinese bond yields could weaken the balance sheet, while core solvency is expected to decline annually.

  Comparison

  The report states that its 7.0% dividend yield leads among Chinese listed insurers and believes the A/H-shares overall offer the most attractive risk-reward.

  Risks

  Asset quality in the banking and asset management businesses, a weaker-than-expected sales recovery, and weaker-than-expected solvency amid macroeconomic volatility.

• Ping An A-shares (601318.SS)

  The report maintains its Overweight rating and top-pick status in the China insurance sector and raises its December 2027 target price to Rmb91.

  Strengths

  Approximately 6x FY27E P/E and a 6.2% dividend yield; improved visibility into double-digit OPAT and DPS growth and improving life insurance and CSM trends.

  Weaknesses

  Low interest rates could constrain solvency capital and dividend capacity, while FY26E P/B remains only 0.9x.

  Comparison

  The report states that the A-shares' 6.2% dividend yield ranks among the highest for Chinese listed insurers.

  Risks

  Asset quality in the banking and asset management businesses, weaker-than-expected NBV and CSM growth, and deterioration in solvency due to macroeconomic volatility.

Key data

• OPAT ForecastsFY26E Rmb151.0bn; FY27E Rmb171.0bn; FY28E Rmb194.0bnCorresponding to year-over-year growth of 12%, 13%, and 13%, modestly higher than previous forecasts.
• DPS ForecastsFY26E Rmb3.00; FY27E Rmb3.39; FY28E Rmb3.85The main text gives year-over-year growth of 11%, 13%, and 13%; the financial tables show 11.3%, 12.9%, and 13.5%.
• CSM Balance ForecastsYear-end 2026 Rmb746.419bn; year-end 2027 Rmb781.045bn; year-end 2028 Rmb824.799bnThe main text uses approximately Rmb746.0bn, Rmb781.0bn, and Rmb825.0bn, with expected year-over-year growth of 2.9%, 4.6%, and 5.6%.
• New Business CSMFY26E Rmb61.160bn; FY27E Rmb77.044bn; FY28E Rmb89.162bnThe report expects new business CSM to exceed CSM release in 2027.
• Core Solvency Adequacy RatioYear-end 2026 164%; year-end 2027 152%; year-end 2028 139%Compared with 166% in June 2026 and 161% at year-end 2025; the report believes it will not constrain growth or shareholder returns during the forecast period.
• Parent-Company Free CashRmb81.7bnUp 20% year-to-date as of June 2026, with upstream dividends sufficient to cover shareholder distributions.
• H-Share Price and Target PriceCurrent price HK$56.60; target price HK$98.00; previous target price HK$95.00Current price as of August 24, 2026; target price corresponds to December 2027.
• A-Share Price and Target PriceCurrent price Rmb54.92; target price Rmb91.00; previous target price Rmb88.00Current price as of August 24, 2026; target price corresponds to December 2027.
• FY27E Valuation and Dividend YieldH-shares at approximately 5x P/E and a 7.0% dividend yield; A-shares at approximately 6x P/E and a 6.2% dividend yieldThe report states that their risk-reward is the most attractive among Chinese insurers.
• P/B Discount2.2x in FY19; 0.8x for H-shares and 0.9x for A-shares in FY26EThe report believes the discount reflects market concerns over low interest rates, solvency, and dividend capacity.
• SOTP Valuation ParametersLife insurance 10x FY27E P/E; non-life insurance 7x; securities 5x; banking 0.4x FY27E BVThe market value of listed fintech and healthtech subsidiaries is also included.

Impact & implications

The report believes Ping An's investment thesis is shifting from market concerns over low interest rates and capital pressure toward a recovery in life insurance new business, renewed CSM accumulation, double-digit OPAT growth, and rising dividends. Parent-company free cash and upstream dividend coverage provide the funding foundation for shareholder returns, while current A/H-share valuations do not yet fully reflect the improvement in fundamentals. Based on this combination, JPMorgan continues to rank Ping An's A-shares and H-shares as its top Overweight picks in the China insurance sector, while noting that solvency remains on a declining trajectory and future delivery depends on the sales recovery, asset quality, and the macroeconomic environment.

Risks

• Asset quality in the banking and asset management businesses may be weaker than expected.
• If the sales recovery falls short of expectations, growth in new business value (NBV) and contractual service margin (CSM) may be insufficient.
• Adverse macroeconomic volatility may result in weaker-than-expected changes in solvency capital.
• Declining Chinese bond yields could weaken the balance sheet and constrain solvency and dividend capacity.

What to watch

• Monitor progress in balance-sheet derisking as the company reduces higher-risk exposures such as equities and non-standard assets.
• Monitor whether new business growth exceeds expectations and whether the agent headcount can achieve net growth in 2026 and beyond.
• Monitor whether new business CSM can exceed CSM release in 2027, thereby driving faster growth in the CSM balance.
• Monitor whether the non-life insurance underwriting cycle is better than expected.
• Monitor whether parent-company cash and upstream dividends can continue to cover business growth and shareholder returns as core solvency declines.